Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases | MicrobiomeTrials← Back to trialsNCT05552469
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2023-05-08Est. Completion: 2027-02-01
Enrollment target: 71 participants Locations- Stanford Cancer Center, Stanford, California, United States
- H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- Sidney Kimmel CCC At JH, Baltimore, Maryland, United States
- Dana Farber Cancer Institute, Boston, Massachusetts, United States
- Mayo Clinic Rochester, Rochester, Minnesota, United States
- Weill Cornell Medicine NY-Presb, New York, New York, United States
- Memorial Sloan Kettering Cancer Ctr, New York, New York, United States
- Vanderbilt University Medical Ctr, Nashville, Tennessee, United States
- Univ of TX MD Anderson Cancer Cntr, Houston, Texas, United States
- Huntsman Cancer Institute, Salt Lake City, Utah, United States
- Novartis Investigative Site, Grenoble, France
- Novartis Investigative Site, Nantes, France
- Novartis Investigative Site, Paris, France
- Novartis Investigative Site, Dresden, Saxony, Germany
- Novartis Investigative Site, Leipzig, Saxony, Germany
Other microbiome trials you might be interested in
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia, Myelodysplasia-RelatedMyelodysplastic Syndrome
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific lab…
Birmingham, United StatesEst. completion May 15, 2029
Novartis Investigative Site, Lübeck, GermanyNovartis Investigative Site, Hong Kong, Hong KongNovartis Investigative Site, Brescia, BS, ItalyNovartis Investigative Site, Rozzano, MI, ItalyNovartis Investigative Site, Singapore, SingaporeNovartis Investigative Site, Madrid, SpainNovartis Investigative Site, Cardiff, United KingdomNovartis Investigative Site, London, United KingdomNovartis Investigative Site, Manchester, United KingdomAcute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Acute Biphenotypic Leukemia
Acute Undifferentiated Leukemia
CLL (Chronic Lymphocytic Leukemia)
Chronic Myeloid Leukemia (CML)
MDS (Myelodysplastic Syndrome)
Non-Hodgkin Lymphomas
Hodgkins Lymphoma
Cutaneous T Cell Lymphomas (CTCL)
The goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marro…
Duarte, United StatesEst. completion Jul 14, 2026
Low-risk Myelodysplastic Syndromes
Phase I study with dose-escalation and expansion evaluating the safety and efficacy of oral Arsenic (ATO) in low-risk My…
Nice, FranceEst. completion Oct 24, 2026